Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - Nature reviews …, 2012 - nature.com
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
[引用][C] Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - NATURE REVIEWS …, 2012 - iris.unipv.it
Targeting MET in cancer: rationale and progress IRIS IRIS Home Sfoglia Macrotipologie &
tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.Catalogo …
tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.Catalogo …
Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - Nature Reviews …, 2012 - go.gale.com
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
[PDF][PDF] Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - NATURE REVIEWS …, 2012 - cellsignet.com
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
Targeting MET in cancer: rationale and progress.
E Gherardi, W Birchmeier, C Birchmeier… - Nature reviews …, 2012 - europepmc.org
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
[引用][C] Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - Nature Reviews …, 2012 - cir.nii.ac.jp
Targeting MET in cancer: rationale and progress | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
[引用][C] Erratum: Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - Nature Reviews …, 2012 - nature.com
In the legend to Figure 6c, the distribution according to therapeutic strategy (monotherapy
versus combined therapy) involving HGF/SF–MET monotherapies should have read 44 …
versus combined therapy) involving HGF/SF–MET monotherapies should have read 44 …
Targeting MET in cancer: rationale and progress.
E Gherardi, W Birchmeier, C Birchmeier… - Nature Reviews …, 2012 - search.ebscohost.com
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - Nature Reviews …, 2012 - edoc.mdc-berlin.de
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier… - Nature reviews …, 2012 - pubmed.ncbi.nlm.nih.gov
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …